MORPHOLINYL CONTAINING BENZIMIDAZOLES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS REPLICATION
申请人:Bonfanti Jean-Francois
公开号:US20080280881A1
公开(公告)日:2008-11-13
The present invention concerns morpholinyl containing benzimidazoles having inhibitory activity on the replication of the respiratory syncytial virus and having the formula
a prodrug, N-oxide, addition salt, quaternary amine, metal complex or stereochemically isomeric form thereof wherein G is a direct bond or optionally substituted C
1-10
alkanediyl; R
1
is Ar
1
or a monocyclic or bicyclic heterocycle Q is R
7
, pyrrolidinyl substituted with R
7
, piperidinyl substituted with R
7
or homopiperidinyl substituted with R
7
; one of R
2a
and R
3a
is selected from halo, optionally mono- or polysubstituted C
1-6
alkyl, optionally mono- or polysubstituted C
2-6
alkenyl, nitro, hydroxy, Ar
2
, N(R
4a
R
4b
), N(R
4a
R
4b
)sulfonyl, N(R
4a
R
4b
)carbonyl, C
1-6
alkyloxy, Ar
2
oxy, Ar
2
C
1-6
alkyloxy, carboxyl, C
1-6
alkyloxycarbonyl, or —C(=Z)Ar
2
; and the other one of R
2a
and R
3a
is hydrogen; in case R
2a
is different from hydrogen then R
2b
is hydrogen, C
1-6
alkyl or halogen and R
3b
is hydrogen; in case R
3a
is different from hydrogen then R
3b
is hydrogen, C
1-6
alkyl or halogen and R
2b
is hydrogen. It further concerns the preparation thereof and compositions comprising these compounds, as well as the use thereof as a medicine.
本发明涉及含有吗啡啉基的苯并咪唑,具有对呼吸道合胞病毒复制的抑制活性,其具有以下式子:
其中G为直接键或可选取代的C1-10烷二基;R1为Ar1或单环或双环杂环;Q为R7、用R7取代的吡咯烷基、用R7取代的哌啶基或用R7取代的同型哌啶基;R2a和R3a中的一个选自卤素、可选单或多取代的C1-6烷基、可选单或多取代的C2-6烯基、硝基、羟基、Ar2、N(R4aR4b)、N(R4aR4b)磺酰基、N(R4aR4b)羰基、C1-6烷氧基、Ar2氧基、Ar2C1-6烷氧基、羧基、C1-6烷氧羰基或—C(=Z)Ar2;而R2a和R3a中的另一个为氢;若R2a不为氢,则R2b为氢、C1-6烷基或卤素,而R3b为氢;若R3a不为氢,则R3b为氢、C1-6烷基或卤素,而R2b为氢。
此外,本发明还涉及其制备方法和包含这些化合物的组合物,以及其作为药物的用途。